Vietnam currently has four Covid-19 vaccines under research by four companies.
Vietnamese scientists are expected to conduct human trials of a locally-made Covid-19 vaccine this month on a group of 60 volunteers, according to the health ministry.
The vaccine has been researched and produced by Nanogen Pharmaceutical Biotechnology Ltd. Co. (Nanogen), one of four companies in Vietnam that are studying Covid-19 vaccines. The company’s vaccine is expected to be the first to reach the stage of human trials.
Vietnam may test Covid-19 vaccine on human in November |
The vaccine has been tested on animals and was also checked by the National Institute of Hygiene and Epidemiology, said Nguyen Ngo Quang, deputy head of the Administration of Science, Technology and Training under the Ministry of Health.
The ministry is currently urging Nanogen to ready the vaccine for human trials right in November, Mr. Quang informed, adding that the ministry required strict compliance with regulations on ensuring safety for volunteers and ethical practices in biomedical research.
Some 187 companies around the world are developing Covid-19 vaccines, of which 38 are being tested on humans. Vietnam’s health ministry and scientists are hoping to have a commercially-viable Covid-19 vaccine in the fourth quarter of 2021.
Vietnam has also registered to receive priority access to a Covid-19 vaccine when it is available on the market.
Vietnam currently has four Covid-19 vaccines under research by Nanogen, Vabiotech, Polyvac and the Institute of Vaccines and Medical Biologicals (IVAC).
Another Vietnamese company, Hanoi-based Vaccine and Biological Production Company No. 1 (VABIOTECH), has also tested Covid-19 vaccines on rhesus macaques (Macaca mulatta). Trials are expected to last around three months. Earlier, VABIOTECH tested Covid-19 vaccines on mice.
Vietnam has recorded 1,192 Covid-19 cases so far, of them 89 are still active. A total of 35 have succumbed to the disease, many being elderly patients with underlying conditions like diabetes or kidney failure. No community transmission has been recorded in two months.
Other News
- Hanoi accelerating efforts to reduce new tuberculosis cases
- Hanoi aims for 94.5% health insurance coverage this year.
- Denmark helps Vietnam enhance primary health care
- Hanoi hospitals to ensure quality healthcare during Tet
- Vietnamese doctors master single-port endoscopy
- EU Green Education: Significant to biodiversity protection in Vietnam
- Health sector joins efforts against climate change
- Treatment abroad no longer necessary for Vietnamese heart patients: Minister of Health
- Hanoi to host ASEAN Cardiology Congress 2023
- WHO praises Vietnam’s public health achievement
Trending
-
World Bank looks forward to stronger ties with Vietnam: country director
-
Vietnam urges respect for international law in East Sea
-
Hanoi kicks off communication contest on Dien Bien Phu victory
-
French education group Odyssey keen on strengthening cooperation with Hanoi
-
Hanoi, Shanghai strengthen investment cooperation
-
UOB Painting of the Year Award opens doors to the world for Vietnamese artists
-
Grapefruit blossom perfume Hanoi's air
-
MICE tourism: Vietnam's lucrative “golden market” unveiled
-
Vietnam: Sleep Tourism on the rise